APP and Alzheimer disease: To further confirm the role of the SARM1-TNF-α pathway in AD, two groups of mice, APP/PS1;SARM1f/f and APP/PS1;SARM1Nestin-CKO mice were treated with the TNF-α inhibitor R-7050 through intraperitoneal injection.